Skip to content
Protocol Guide

The Wolverine Stack: BPC-157 + TB-500 Combination Guide

Everything about the Wolverine Stack — the popular BPC-157 and TB-500 peptide combination used for accelerated recovery. Protocols, dosing, timing, and what users report.

10 min readUpdated Mar 10, 2026

What Is the Wolverine Stack?

The "Wolverine Stack" is a nickname for the combination of BPC-157 and TB-500 (Thymosin Beta-4), two peptides that are each individually studied for tissue repair and recovery. The name references Wolverine from the X-Men — the character famous for his rapid healing ability.

This combination became popular in fitness and biohacking communities around 2019-2020 and has remained one of the most discussed peptide protocols since. It's important to note upfront: there are no published studies testing this specific combination. The rationale is theoretical, and the reported results are entirely anecdotal.

Why Combine BPC-157 and TB-500?

The logic behind combining these two peptides is based on their complementary mechanisms of action.

BPC-157 primarily works by promoting angiogenesis (new blood vessel formation) at injury sites, delivering the blood supply needed for repair. It has particularly strong evidence in tendon healing and gastrointestinal protection.

TB-500 works by regulating actin, a key structural protein in cells, which promotes cell migration — essentially helping repair cells travel to where they're needed. It also has strong anti-inflammatory effects.

The Complementary Theory

Think of it this way: BPC-157 builds the roads (blood vessels) to the injury site, and TB-500 drives the repair trucks (cells) along those roads. Together, they could theoretically create a more complete healing response than either alone.

This is a reasonable hypothesis, but hypothesis is all it is. No one has tested whether using both together produces better outcomes than using either alone. It's possible the effects are additive, synergistic, or simply redundant.

The Protocol

The following protocols are based on commonly reported dosing patterns in online communities and from peptide clinics. These are not medically established protocols. For foundational dosing info, see our BPC-157 dosage guide.

Standard Wolverine Stack

BPC-157
250 – 500 mcg / day
Administered once or twice daily via subcutaneous injection. Some users split the dose into morning and evening.
TB-500
2 – 2.5 mg / 2x per week
Loading phase (first 4 weeks): 2-2.5mg twice per week. Maintenance (weeks 5+): 2mg once per week or as needed.

Common cycle structure

Weeks 1-4 (Loading): BPC-157 at 500 mcg daily + TB-500 at 2.5 mg twice weekly. This is the aggressive phase where both compounds are at higher doses. The idea is to kickstart the healing process.

Weeks 5-8 (Maintenance): BPC-157 at 250 mcg daily + TB-500 at 2 mg once weekly. Reduced dosing to maintain the effect while reducing compound exposure.

Weeks 9-12 (Optional extension): Some users continue BPC-157 alone at 250 mcg daily while discontinuing TB-500. This is common when gut support or localized healing is still desired.

Timing & Administration

Can you inject them together?

Many users reconstitute both peptides separately and draw from both vials into a single syringe for one injection. No chemical incompatibility has been reported, though this hasn't been formally studied. Others prefer separate injections for more precise dosing control.

Where to inject

BPC-157 is commonly injected subcutaneously near the injury site for targeted issues, or in the abdominal fat pad for systemic or gut-related use. TB-500, being more systemic by nature, is typically injected subcutaneously in the abdomen or deltoid regardless of injury location.

Time of day

No evidence suggests a particular time is optimal. Some users prefer morning dosing, while others inject before bed theorizing that growth hormone release during sleep enhances the effect. This is speculative. Consistency likely matters more than timing.

Reconstitution tip

Both peptides come as lyophilized (freeze-dried) powder and require reconstitution with bacteriostatic water. Use gentle swirling — never shake the vial. Store reconstituted peptides refrigerated at 2-8°C and use within 3-4 weeks.

What Users Report

The following timeline is compiled from user reports across forums, Reddit, and peptide community discussions. Individual experiences vary enormously, and placebo effect cannot be ruled out.

Timeline Commonly Reported Effects
Days 1-3 Mild warmth or tingling at injection site. Some report improved sleep quality.
Week 1 Reduced pain at injury sites. Some users notice improved gut comfort and digestion.
Weeks 2-3 More noticeable reduction in inflammation. Improved range of motion in injured joints. Some report increased energy.
Weeks 4-6 Significant improvement in injury symptoms. Users with tendon issues often report the most dramatic changes in this window.
Weeks 6-8 Continued improvement or stabilization. Some users feel they've reached maximum benefit by this point.
Anecdotal ≠ Evidence

User reports are subject to placebo effect, confirmation bias, and concurrent treatments (many users also change their rehab protocols, diet, or other supplements simultaneously). Treat these timelines as rough guides, not guarantees.

Cost Breakdown

Running the Wolverine Stack is not cheap. Here's a rough estimate for an 8-week protocol at standard dosing, based on typical research peptide pricing.

Item Amount Needed Estimated Cost
BPC-157 (5mg vials) 4-5 vials for 8 weeks at 500mcg/day 20 – $300
TB-500 (5mg vials) 4-6 vials for loading + maintenance 60 – $480
Bacteriostatic water 2-3 vials (30ml each) 5 – $30
Insulin syringes ~60 for 8 weeks 0 – $20
Alcohol swabs 1 box $5 – 0
Total estimate $310 – $840

Prices vary significantly by supplier and region. The wide range reflects the difference between budget research suppliers and premium peptide companies. Quality testing adds cost but is strongly recommended.

Safety Considerations

The safety considerations for the Wolverine Stack include everything that applies to BPC-157 and TB-500 individually, plus additional unknowns from the combination.

No interaction studies exist. While users report the combination is well-tolerated, no one has formally studied whether BPC-157 and TB-500 interact in unexpected ways at the molecular level.

Additive angiogenic effect. Both peptides promote blood vessel formation. The theoretical risk is that combining two angiogenic compounds could be problematic for individuals with conditions where new blood vessel growth is undesirable (certain cancers, diabetic retinopathy, etc.).

Source quality is paramount. Running two research peptides simultaneously doubles your exposure to quality risks. Insist on third-party COAs for both compounds.

Legal status. Both BPC-157 and TB-500 are banned by WADA and face increasing regulatory scrutiny. See our peptide legality guide for current status.

FAQ

Is the Wolverine Stack worth the cost vs just using one peptide?

There's no evidence it's more effective than using either peptide alone. Some users report better results with the combination, but this could reflect higher total peptide dose rather than true synergy. If budget is a concern, starting with BPC-157 alone is the more common recommendation — it's cheaper and has a broader evidence base.

Can I take the Wolverine Stack orally?

BPC-157 appears to be orally bioavailable, but TB-500 is not. If you want an all-oral approach, you'd be limited to BPC-157 only. Some users take BPC-157 orally while injecting TB-500, which is a valid hybrid approach.

Do I need PCT (post cycle therapy) after the Wolverine Stack?

No. Neither BPC-157 nor TB-500 affects hormonal axes (testosterone, estrogen, etc.), so PCT is not applicable. This is different from anabolic steroids or SARMs.

Who should NOT use the Wolverine Stack?

Given the lack of human safety data, extreme caution is advised for anyone with active cancer or a history of cancer, pregnant or breastfeeding women, individuals under 18, competitive athletes (both compounds are WADA-banned), and anyone on immunosuppressive therapy.

Medical Disclaimer: This content is for informational and educational purposes only. It is not intended as medical advice and should not replace consultation with a qualified healthcare professional. BPC-157 and related peptides are research compounds and are not approved by the FDA for human use.